As shown in Fig. 3A, the expression of HOXD10 was frequently downregulated in glioma tissues compared to their matched adjacent tissues, which correlates with the expression of miR-23a and further indicates that HOXD10 is a target of miR-23a in glioma. Here, HOXD10 is linked to central nervous system cancer.